NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

Patients with hypertension stand to benefit from exercise prescriptions; reliance on AI might erode physicians’ skills; and a ...

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

A once-daily polypill containing 3 guideline-directed therapies for heart failure with reduced ejection fraction (HFrEF) led ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for ...

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...

The Indian Polycap Study (TIPS). Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet ...

The phase III trial studying CRISPR gene editing therapy for transthyretin amyloidosis (ATTR) was paused for safety due to an alarming case of poor liver function in one patient, Intellia Therapeutics ...

Integrating nephrology and cardiology care for patients with kidney and cardiovascular (CV) risks can be challenging but is ...

Persistent Pollutant May Raise Parkinson's Disease Risk A recent study is the first to suggest a potential link between long-term exposure to high levels of trichloroethylene and an increased risk for ...